367 related articles for article (PubMed ID: 16574521)
1. Fever without source in children 0 to 36 months of age.
Ishimine P
Pediatr Clin North Am; 2006 Apr; 53(2):167-94. PubMed ID: 16574521
[TBL] [Abstract][Full Text] [Related]
2. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center.
Stoll ML; Rubin LG
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):671-5. PubMed ID: 15237067
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine.
Waddle E; Jhaveri R
Arch Dis Child; 2009 Feb; 94(2):144-7. PubMed ID: 18539684
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
Adam D; Fehnle K
Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
[TBL] [Abstract][Full Text] [Related]
6. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).
Isaacman DJ; Fletcher MA; Fritzell B; Ciuryla V; Schranz J
Vaccine; 2007 Mar; 25(13):2420-7. PubMed ID: 17049677
[TBL] [Abstract][Full Text] [Related]
7. Management of fever without source in infants and children.
Baraff LJ
Ann Emerg Med; 2000 Dec; 36(6):602-14. PubMed ID: 11097701
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine.
Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH
Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092
[TBL] [Abstract][Full Text] [Related]
9. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
[TBL] [Abstract][Full Text] [Related]
10. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.
Bolton M; Barson W
Pediatr Ann; 2010 Aug; 39(8):497-503. PubMed ID: 20704146
[No Abstract] [Full Text] [Related]
11. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
12. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].
Blanco Quirós A; Giménez Sánchez F; Asensi Botet F; Bernaola Iturbe E; Martín Fde J; García Pérez J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V;
An Esp Pediatr; 2002 Oct; 57(4):287-9. PubMed ID: 12392660
[No Abstract] [Full Text] [Related]
13. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
[TBL] [Abstract][Full Text] [Related]
14. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.
Nigrovic LE; Kuppermann N; Malley R;
Acad Emerg Med; 2008 Jun; 15(6):522-8. PubMed ID: 18616437
[TBL] [Abstract][Full Text] [Related]
15. Prevention of otitis media: role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance.
Jacobs MR
J Pediatr; 2002 Aug; 141(2):287-93. PubMed ID: 12183732
[No Abstract] [Full Text] [Related]
16. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
[TBL] [Abstract][Full Text] [Related]
17. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS
Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392
[TBL] [Abstract][Full Text] [Related]
18. Prevnar(tm): a pneumococcal conjugate vaccine for infants and young children.
Brown A
Issues Emerg Health Technol; 2001 Feb; (14):1-6. PubMed ID: 11902222
[No Abstract] [Full Text] [Related]
19. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
[TBL] [Abstract][Full Text] [Related]
20. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):1-4. PubMed ID: 19145219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
